Form 483

ABC Compounding Co., Inc. Form 483, 2018-04-19

FDA issued a Form 483 to ABC Compounding Co., Inc. on 2018-04-19 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

ABC Compounding Co., Inc. · Conyers, United States · Issued April 19, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Apr 2018
21 CFR 211.125(a)

Strict control not exercised over labeling issued

Cited by Jared P Stevens

19 Apr 2018
21 CFR 211.170(b)

Drug product reserve containers

Cited by Jared P Stevens

19 Apr 2018
21 CFR 211.186(a)

Master production and control records, procedure

Cited by Jared P Stevens

19 Apr 2018
21 CFR 211.196

Distribution Record Requirements

Cited by Jared P Stevens

Inspected site

ACABC Compounding Co., Inc.Conyers, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.125(a)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.186(a)Cited across public-safe Form 483 observations1x
21 CFR 211.196Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere